• 1
    JS Berek. Practical gynecological oncology, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 2004.
  • 2
    Rose PG, Piver MS, Tsukada Y, Lau TS. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 1989;64:150813.
  • 3
    Reed E, Zerbe CS, Brawley OW, Bicher A, Steinberg SM. Analysis of autopsy evaluations of ovarian cancer patients treated at the National Cancer Institute, 1972–1988. Am J Clin Oncol 2000;23:10716.
  • 4
    O’Hanlan KA, Kargas S, Schreiber M et al. Ovarian carcinoma metastases to gastrointestinal tract appear to spread like colon carcinoma: implications for surgical resection. Gynecol Oncol 1995;59:2006.
  • 5
    Chan JK, Zhang M, Kaleb V et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary—a multivariate analysis. Gynecol Oncol 2005;96:2049.
  • 6
    Zhang J, Young RH, Arseneau J, Scully RE. Ovarian stromal tumors containing lutein or Leydig cells (luteinized thecomas and stromal Leydig cell tumors)—a clinicopathological analysis of fifty cases. Int J Gynecol Pathol 1982;1:27085.
  • 7
    Paoletti M, Pridjian G, Okagaki T, Talerman A. A stromal Leydig cell tumor of the ovary occurring in a pregnant 15-year-old girl. Ultrastructural findings. Cancer 1987;60:280610.
  • 8
    Takeuchi S, Ishihara N, Ohbayashi C, Itoh H, Maruo T. Stromal Leydig cell tumor of the ovary. Case report and literature review. Int J Gynecol Pathol 1999;18:17882.
  • 9
    Brown J, Shvartsman HS, Deavers MT et al. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 2005;97:48996.
  • 10
    Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 1999;72:1317.